Literature DB >> 1984460

Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.

J L Arciniega1, E L Hewlett, F D Johnson, A Deforest, S G Wassilak, I M Onorato, C R Manclark, D L Burns.   

Abstract

The human serologic response to several envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis was examined using immunoblot techniques. Antigens recognized by sera from individuals with culture-confirmed pertussis and by sera from infants immunized with three doses of conventional whole-cell pertussis vaccine included a 63,000-Da protein that was shown to be antigenically related to a mycobacterial heat-shock protein. A 29,000-Da protein reacted with sera from convalescent individuals, whereas a 91,000-Da protein reacted with sera from vaccinated individuals. Antibodies to adenylate cyclase toxin were common in sera from individuals diagnosed with pertussis. B. pertussis lipooligosaccharide was also recognized by antibodies in some of these sera. These data suggest that some of these antigens may play a role in immunity to pertussis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984460     DOI: 10.1093/infdis/163.1.135

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.

Authors:  M K Gross; D C Au; A L Smith; D R Storm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 4.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

7.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Western blot analysis of antibody responses of young infants to pertussis infection.

Authors:  N Guiso; E Grimprel; I Anjak; P Bégué
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

9.  CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection.

Authors:  E Grimprel; P Bégué; I Anjak; F Betsou; N Guiso
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.